AU7617791A - Recombinant immunocastration vaccine - Google Patents

Recombinant immunocastration vaccine

Info

Publication number
AU7617791A
AU7617791A AU76177/91A AU7617791A AU7617791A AU 7617791 A AU7617791 A AU 7617791A AU 76177/91 A AU76177/91 A AU 76177/91A AU 7617791 A AU7617791 A AU 7617791A AU 7617791 A AU7617791 A AU 7617791A
Authority
AU
Australia
Prior art keywords
recombinant
immunocastration
vaccine
immunocastration vaccine
recombinant immunocastration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU76177/91A
Other versions
AU634379B2 (en
Inventor
John Cooper Cox
Stirling John Edwards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CSL Ltd
Original Assignee
CSL Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CSL Ltd filed Critical CSL Ltd
Priority to AU76177/91A priority Critical patent/AU634379B2/en
Priority to AU16495/92A priority patent/AU1649592A/en
Priority to PCT/AU1992/000194 priority patent/WO1992019746A1/en
Publication of AU7617791A publication Critical patent/AU7617791A/en
Application granted granted Critical
Publication of AU634379B2 publication Critical patent/AU634379B2/en
Assigned to CSL LIMITED reassignment CSL LIMITED Request to Amend Deed and Register Assignors: COMMONWEALTH SERUM LABORATORIES LIMITED
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
AU76177/91A 1991-04-29 1991-04-29 Recombinant immunocastration vaccine Ceased AU634379B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU76177/91A AU634379B2 (en) 1991-04-29 1991-04-29 Recombinant immunocastration vaccine
AU16495/92A AU1649592A (en) 1991-04-29 1992-04-29 Recombinant immunocastration vaccine and polypeptides useful for same
PCT/AU1992/000194 WO1992019746A1 (en) 1991-04-29 1992-04-29 Recombinant immunocastration vaccine and polypeptides useful for same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU76177/91A AU634379B2 (en) 1991-04-29 1991-04-29 Recombinant immunocastration vaccine

Publications (2)

Publication Number Publication Date
AU7617791A true AU7617791A (en) 1992-11-19
AU634379B2 AU634379B2 (en) 1993-02-18

Family

ID=3757312

Family Applications (1)

Application Number Title Priority Date Filing Date
AU76177/91A Ceased AU634379B2 (en) 1991-04-29 1991-04-29 Recombinant immunocastration vaccine

Country Status (2)

Country Link
AU (1) AU634379B2 (en)
WO (1) WO1992019746A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062657A2 (en) * 1999-04-15 2000-10-26 Monash University Improvement of t cell mediated immunity

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
DK96493D0 (en) * 1993-08-26 1993-08-26 Mouritsen Og Elsner Aps PROCEDURE FOR INDUCING ANTIBODY RESPONSE TO SELF-PROTEINS AND AUTOVACCINE PROCESSED BY THE PROCEDURE
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
US6352972B1 (en) * 1995-06-06 2002-03-05 Marcel E. Nimni Bone morphogenetic proteins and their use in bone growth
CU22627A1 (en) * 1996-12-17 2000-12-22 Ct Ingenieria Genetica Biotech VACCINE PREPARATION FOR THE REVERSIBLE IMMUNE-CASTRATION OF MAMMALS
PL194221B1 (en) 1997-04-15 2007-05-31 Pharmexa As Modified tnfalpha molecule, dna encoding such molecule and vaccine comprising such tnfalpha molecule and such dna
US6013770A (en) * 1997-07-21 2000-01-11 Washington State University Chimeric contraceptive vaccines
AU2001259452A1 (en) 2000-05-05 2001-11-20 Aphton Corporation Chimeric peptide immunogens their preparation and use
WO2004000343A1 (en) * 2002-06-19 2003-12-31 Nexgen Biotechnologies, Inc. Recombinant polypeptide for immunocastration and vaccine comprising the same
AU2005282231B2 (en) * 2004-09-10 2011-03-10 The Council Of The Queensland Institute Of Medical Research (Qimr) Truncated LHRH formulations
BRPI0515076A (en) * 2004-09-10 2008-07-01 Queensland Inst Med Res peptide, composition, lipopeptide, method of generating an anti-lhrh response in an animal and use of a peptide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
US4975420A (en) * 1987-09-30 1990-12-04 University Of Saskatchewan Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals
DK8189A (en) * 1988-01-12 1989-07-13 Bunge Australia ANTIGEN-ANTIBODY CONJUGATES, THEIR PREPARATION AND USE
AU622044B2 (en) * 1989-08-25 1992-03-26 Biotechnology Australia Proprietary Limited Fusion proteins

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000062657A2 (en) * 1999-04-15 2000-10-26 Monash University Improvement of t cell mediated immunity
WO2000062657A3 (en) * 1999-04-15 2001-01-11 Univ Monash Improvement of t cell mediated immunity

Also Published As

Publication number Publication date
AU634379B2 (en) 1993-02-18
WO1992019746A1 (en) 1992-11-12

Similar Documents

Publication Publication Date Title
CZ197595A3 (en) Vaccine preparations
AU6018194A (en) Easy intubator
ZA922011B (en) Vaccine
ZA928511B (en) Peptides
AU1219292A (en) Inhaler
AU2421192A (en) Inhaler
AU1823492A (en) Imidazodiazepines
AU2857692A (en) Tri-arginine insulins
AU2121092A (en) Benzodioxanderivate
AU1930992A (en) Pyrrolopyrazines
AU1782292A (en) Gridbeam
AU7617791A (en) Recombinant immunocastration vaccine
AU2135292A (en) Cyanophenylpyrroles
AU1556892A (en) 2-substituted-2-imidazolines
AU2636292A (en) Anti-alpha6-integrin-antibodies
AU1080292A (en) Ige-receptor-antibodies
AU6715094A (en) Recombinant vaccine
AU2010992A (en) Novel azabicyclobenzisoquinolines
AU2586192A (en) Imaginograph
AU1668097A (en) Malaria recombinant poxvirus vaccine
AU1752492A (en) Diamino-alpha-alkylstilbenes
AU2347692A (en) Recombinant viral vaccine
AU2040192A (en) Quinolin-2-yl-methoxybenzylhydroxyureas
AU1346092A (en) Angiogenic peptides
AU3048689A (en) Immunogenic peptides